Press Releases

Featured Press Releases

BIO Statement on Passage of Bipartisan…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement.“The passage of the Mikaela Naylon Give Kids a Chance Act is a bipartisan victory for children and…

Learn more

BIO Appoints Joe Franklin, JD, PhD, as Chief…

Washington, D.C. (February 2, 2026) -- The Biotechnology Innovation Organization (BIO) today named Joe Franklin, JD, PhD, as its new chief legal and policy officer. Franklin brings deep expertise in the biomedical sector across law, policy, AI, and…

Learn more

Biotechnology Innovation Organization (BIO)…

WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…

Learn more

BIO Opens Nominations for the Third Annual Rosalind Franklin Award

February 10, 2016

The Rosalind Franklin Award is given annually to an outstanding woman in the industrial biotechnology sector who has made significant contributions to the advancement of the biobased economy and biotech innovation. The Biotechnology Innovation…

BIO Applauds Advancement of Senate Innovation Initiative Legislation

February 10, 2016

The Biotechnology Innovation Organization (BIO) applauds the passage yesterday by the Senate Health Committee of legislative components of the bipartisan Innovation Initiative to accelerate the pace of medical advancement.

President’s Proposed 2017 Budget Poses Threat to Medical Innovation

February 9, 2016

Elements of the President’s budget proposal for 2017 directly threaten his Administration’s goal of curing cancer through advances in precision medicine

BIO Premieres New Ad Highlighting the Value of Biomedical Innovation

February 8, 2016

Ad Launches Campaign Spotlighting Benefits and Value of Medical Breakthroughs

BIO Releases First-Ever Industry Principles on Value of Biopharmaceuticals

February 3, 2016

Innovative biopharmaceutical industry focused on value, advocating for needed reforms

BIO Applauds House for Passing Legislation to Enhance Small Businesses’ Voice at the SEC

February 2, 2016

BIO applauds the House of Representatives for approving the SEC Small Business Advocate Act (H.R. 3784) and the Small Business Capital Formation Enhancement Act (H.R. 4168). These bills would enhance the role that small businesses play in the…

Nominations Now Open for the BIO George Washington Carver Award for Innovation in Industrial Biotechnology

February 1, 2016

The ninth annual George Washington Carver Award will recognize an individual who has made a significant contribution to building the biobased economy by applying industrial biotechnology to create sustainable and environmentally…

BIO Opens Registration for the 13th Annual World Congress on Industrial Biotechnology in San Diego

January 26, 2016

The Biotechnology Innovation Organization (BIO) opened registration today for the 2016 World Congress on Industrial Biotechnology. The conference will be held April 17-20, 2016 in San Diego, California.

BIO Applauds Declaration on Combating Antimicrobial Resistance

January 21, 2016

Washington, D.C. (January 21, 2016) – The Biotechnology Innovation Organization (BIO) applauds the Industry Declaration on Combating Antimicrobial Resistance, signed by 85 biopharmaceutical and diagnostic companies and released today at the World…

BIO President and CEO Jim Greenwood to Chair BIO Ventures for Global Health Board of Directors

January 21, 2016

BVGH engages leading biopharmaceutical companies in partnerships and programs to address challenging global health issues

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.